AKTS
Aktis Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$27.05
+1.50%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 123.02x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.10x
- Price / sales
- 159.82x
- Price / cash flow
- -20.65x
Enterprise value
- Enterprise value
- $998.4M
- EV / sales
- 106.06x
- EV / EBITDA
- -13.92x
- EV / EBIT
- -11.80x
- Market cap
- $1.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026